THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

摘要

The disclosure provides a pharmaceutical composition comprising a compound of the Formulaoror a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable excipient, wherein the composition is formulated for oral administration to a human and contains 0.2 mg to 500 mg of the compound or a salt thereof.